RE:RE:Excellent Q1 Medipharm :) To bad market doesn't see it !This isn't about 'getting the word out', they issue their releases for the masses but the real money doesn't wait for the releases.
The Q1 numbers were good, but not great. Pidduck and Hunter are the real deals and have done what was needed to put this business on solid footing. I'm not sure Strachan is up for the role he's in and personally I think the business would be better served with someone more senior and polished in a role like that. We need someone who knows how to grow a business and has a long contact list to leverage, and I don't think Keith has that. Doubt Pidduck has the stones to fire him, and maybe he can't but having a real #2 would serve shareholders well.
That said, I am as pissed off with their lack of transparency as the next guy. The corporate deck is over a year old, no word on breakeven projection, no word on Brazil partner, no word on A/NDA or 505 submission, no word on damn near anything except for the 'percentage increases' in top and bottom lines. As much as I like Greg telling me about the numbers and that we're not bleeding anymore, it's pretty bad when the CFO is the one that talks to most on the call and basically says the same things over and over just to fill time. Great, the business grew a bit and there's $17mil in the treasury. Next.
Hopefully Pidduck puts out a corporate update release by months end to let the angry mob know that we're not forgotten and that things are actually happening and puts some specificity on the strategic items that are supposed to be in flight. They shouldn't simply be ok with, the business is going to grow slowly, trust us message, at least not anymore. The business opened various cans of worms, the shareholders won't forget about them. Tell us.